Tandem Diabetes Care Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名80/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价23.09。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Tandem Diabetes Care Inc评分
相关信息
行业排名
80 / 208
全市场排名
188 / 4562
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Tandem Diabetes Care Inc亮点
亮点风险
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
公司代码TNDM
公司Tandem Diabetes Care Inc
CEOSheridan (John F)
网址https://www.tandemdiabetes.com/
常见问题
Tandem Diabetes Care Inc(TNDM)的当前股价是多少?
Tandem Diabetes Care Inc(TNDM)的当前股价是 21.700。
Tandem Diabetes Care Inc的股票代码是什么?
Tandem Diabetes Care Inc的股票代码是TNDM。
Tandem Diabetes Care Inc股票的52周最高点是多少?
Tandem Diabetes Care Inc股票的52周最高点是37.930。
Tandem Diabetes Care Inc股票的52周最低点是多少?
Tandem Diabetes Care Inc股票的52周最低点是9.980。
Tandem Diabetes Care Inc的市值是多少?
Tandem Diabetes Care Inc的市值是1.47B。
Tandem Diabetes Care Inc的净利润是多少?
Tandem Diabetes Care Inc的净利润为-96.03M。
现在Tandem Diabetes Care Inc(TNDM)的股票是买入、持有还是卖出?
根据分析师评级,Tandem Diabetes Care Inc(TNDM)的总体评级为买入,目标价格为23.091。
Tandem Diabetes Care Inc(TNDM)股票的每股收益(EPS TTM)是多少
Tandem Diabetes Care Inc(TNDM)股票的每股收益(EPS TTM)是-3.030。